Search results
Sweden stocks lower at close of trade; OMX Stockholm 30 down 0.99% By Investing.com
Investing.com· 1 day agoSweden stocks lower at close of trade; OMX Stockholm 30 down 0.99%
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Morningstar· 3 days agoAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children 10 and older. Farxiga, which goes by generic ...
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Market Watch· 3 days agoPublished: June 12, 2024 at 6:01 p.m. ETShareResizeBy Ben GlickmanAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children ...
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks· 2 days agoFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
Tempus AI shares jump 8% in strong Nasdaq debut as US IPO market thaws
Reuters via Yahoo Finance· 1 day agoTempus' customers include major drugmakers such as AstraZeneca and GSK. It competes with Swiss...
Another Approach To Checkpoint Inhibitors: Targeting Receptors
Forbes· 6 days agoAn alternative to PD-1 targeting cancer therapies, PD-L1 checkpoint inhibitors boost antitumor...
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 3 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Lung cancer: Why non-smokers don't respond to treatments
Medical News Today· 2 days agoResearchers report that people who have never smoked are less likely to respond to standard...
Broadcom Joins Nvidia, Cava On List Of 19 'Perfect' Stocks
Investor's Business Daily· 22 hours ago...ACM Research ACMR 99 99 94 A B- Argan AGX 99 90 97 B A Arm Holdings ARM 99 99 98 A A+ Broadcom...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 1 day agoThe FDA approved AstraZeneca’s AZN type-II diabetes (T2D) medicine, Farxiga, for pediatric...